BRIDGEWATER, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) approval of ...

Amneal plans to launch the product in the third quarter of 2025. According to IQVIA, U.S. annual sales for prednisolone acetate ophthalmic suspension for the 12 months ended April 2025 were about ...

Key complex product approval in the Affordable Medicines segment this year Commercial launch planned for third quarter of 2025 BRIDGEWATER, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Amneal ...

USMNT focus, team news Diego Luna has used this Gold Cup as his personal playground and breakout moment with three goals, including both in the USMNT’s 2-1 victory over Guatemala in the semifinals, ...

Patients should be treated with anti-inflammatories for 7 to 14 days postprocedure, specifically a corticosteroid 4 times per day such as Pred Forte (Allergan Inc., Irvine, CA), prednisolone ...

In 2023, the U.S. uveitis treatment market was valued at USD 0.71 billion and is forecast to grow to USD 1.44 billion by 2032, reflecting a CAGR of 8.09% during the forecast period. The U.S ...

SNS Insider Reveals Strategic Outlook for the U.S. Uveitis Treatment Market—Valued at USD 0.71 Billion in 2023—With the Nation Poised to Maintain North American Dominance Amid Rising Adoption of ...

Although not as effective as oral acetazolamide, topical dorzolamide was reported to provide significant intraocular pressure reduction in one group of 11 pediatric glaucoma patients (35.7% and 27 ...